Skip to main content
. 2021 Mar 22;11:609334. doi: 10.3389/fonc.2021.609334

Figure 4.

Figure 4

Survival analysis and risk score. (A) CD163 (TCGA: P = 0.039), (B) MMD (TCGA: P = 0.047), (C) CSF1 (TCGA: P = 0.013), (D) CD209 (TCGA: P < 0.001). Cox regression risk score model based on these genes. Risk score = 1 * CD163 + 1 * CD209 + 1 * CSF1 + 1 * MMD. (E) The patients in high risk groups for bladder patients (TCGA: P < 0.001; HR = 1.88) showed survival risk against low expression groups. (F) Area under curve = 0.640.